Target intelligence / Profile preview

DDB1- and CUL4-associated factor 5 (DCAF5)

Target
DCAF5
Molecular classification
Substrate receptor, E3 ubiquitin ligase complex component, WD repeat domain protein, Other
01

Overview

DDB1- and CUL4-associated factor 5 (DCAF5) is a substrate receptor protein for the CUL4-DDB1 E3 ubiquitin ligase complex[2][6]. It contains WD repeat domains and mediates ubiquitination and degradation of specific protein substrates, including incompletely assembled SWI/SNF chromatin remodeling complexes in the absence of SMARCB1[1][4][2]. DCAF5 is essential for the survival of SMARCB1-mutant cancer cells because it clears defective SWI/SNF complexes, a process critical to the oncogenic state in these cancers. Loss or inhibition of DCAF5 in SMARCB1-deficient cells leads to reaccumulation of functional chromatin remodeling complexes and reversal of malignancy phenotypes[1][4]. DCAF5 also plays roles in developmental regulation and cellular homeostasis, with genomic deletion associated with neurodevelopmental phenotypes[2][5][7]. Its WD repeat domain structure provides a potential druggable site, but clinical inhibitors or drugs directly targeting DCAF5 are not yet established[4].

Other names
BCRG2KIAA1824WDR22BCRP2D14S1461EBreakpoint cluster region protein 2WD repeat-containing protein 22
02

Mechanism of action

Targeting DCAF5 inhibits its E3 ligase function, stabilizes partially assembled SWI/SNF complexes, and restores chromatin remodeling activity in SMARCB1-mutant cancers[1][4].

03

Biological functions

Protein ubiquitinationUbiquitin-mediated proteolysisQuality control of protein complexesCell cycle regulationRegulation of fatty acid biosynthetic processChromatin remodeling complex turnover
04

Disease associations

Cancer (notably SMARCB1-mutant malignancies)Neurodevelopmental disorders (via genomic deletions)Congenital heart defectsOther
05

Safety considerations

Broad role in protein quality control may present toxicity concerns if inhibited systemicallycrucial for normal development and protein turnover[2]
06

Biomarkers

SMARCB1 status (loss-of-function) as a vulnerability biomarker for DCAF5 targeting[1][4]

Beyond the preview

Go deeper on DDB1- and CUL4-associated factor 5 (DCAF5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DDB1- and CUL4-associated factor 5 (DCAF5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call